Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 2/20 | 0.57 |
| ▸ | CA12 | O43570 | 2/20 | 0.57 |
| ▸ | CA1 | P00915 | 2/20 | 0.57 |
| ▸ | CA2 | P00918 | 2/20 | 0.57 |
| ▸ | CA7 | P43166 | 2/20 | 0.57 |
| ▸ | CA9 | Q16790 | 2/20 | 0.57 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | HPGD | P15428 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 2/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL542210 | 0.88 | CA1 (0.57) | XDHCA12CA1CA2CA7 | |
| SCHEMBL8567407 | 0.86 | PTPN1 (0.46) | XDHCA12CA1CA2CA7 | |
| SCHEMBL15657532 | 0.86 | CA1 (0.59) | XDHCA12CA1CA2CA7 | |
| SCHEMBL9107524 | 0.84 | KDM4E (0.49) | XDHCA12CA1CA2CA7 | |
| SCHEMBL6899135 | 0.84 | LMNA (0.44) | XDHCA12CA1CA2CA7 | |
| SCHEMBL20455949 | 0.83 | MAPT (0.53) | XDHCA12CA1CA2CA7 | |
| SCHEMBL29645074 | 0.82 | HTT (0.53) | LMNAHPGDALDH1A1MEN1HTT | |
| SCHEMBL1091841 | 0.82 | HTT (0.53) | LMNAHPGDALDH1A1MEN1HTT | |
| SCHEMBL9907323 | 0.82 | KDM4E (0.43) | XDHCA12CA1CA2CA7 | |
| SCHEMBL3373567 | 0.82 | CA12 (0.67) | XDHCA12CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220213020-A1 | SYNTHESIS OF INTERMEDIATES FOR PRODUCING PROSTACYCLIN DERIVATIVES | UNITED THERAPEUTICS CORPORATION (US) | 2022-07-07 | — | — | US | disclosed |
| US-11225452-B2 | Synthesis of intermediates for producing prostacyclin derivatives | UNITED THERAPEUTICS CORPORATION (US) | 2022-01-18 | — | — | US | disclosed |
| US-20200369592-A1 | SYNTHESIS OF INTERMEDIATES FOR PRODUCING PROSTACYCLIN DERIVATIVES | UNITED THERAPEUTICS CORPORATION (US) | 2020-11-26 | — | — | US | disclosed |
| US-10774027-B2 | Synthesis of intermediates for producing prostacyclin derivatives | UNITED THERAPEUTICS CORPORATION (US) | 2020-09-15 | — | — | US | disclosed |
| EP-3209415-B1 | SYNTHESIS OF INTERMEDIATES FOR PRODUCING PROSTACYCLIN DERIVATIVES | UNITED THERAPEUTICS CORP (US) | 2020-02-19 | — | — | EP | disclosed |
| US-20190233362-A1 | SYNTHESIS OF INTERMEDIATES FOR PRODUCING PROSTACYCLIN DERIVATIVES | UNITED THERAPEUTICS CORPORATION (US) | 2019-08-01 | — | — | US | disclosed |
| US-10196342-B2 | Synthesis of intermediates for producing prostacyclin derivatives | UNITED THERAPEUTICS CORPORATION (US) | 2019-02-05 | — | — | US | disclosed |
| US-20170158602-A1 | SYNTHESIS OF INTERMEDIATES FOR PRODUCING PROSTACYCLIN DERIVATIVES | UNITED THERAPEUTICS CORPORATION (US) | 2017-06-08 | — | — | US | disclosed |
| US-20170158602-A1 | SYNTHESIS OF INTERMEDIATES FOR PRODUCING PROSTACYCLIN DERIVATIVES | UNITED THERAPEUTICS CORPORATION (US) | 2017-06-08 | — | — | US | disclosed |
| US-9593061-B2 | Synthesis of intermediates for producing prostacyclin derivatives | UNITED THERAPEUTICS CORPORATION (US) | 2017-03-14 | — | — | US | disclosed |
| US-9593061-B2 | Synthesis of intermediates for producing prostacyclin derivatives | UNITED THERAPEUTICS CORPORATION (US) | 2017-03-14 | — | — | US | disclosed |
| US-20160107973-A1 | SYNTHESIS OF INTERMEDIATES FOR PRODUCING PROSTACYCLIN DERIVATIVES | UNITED THERAPEUTICS CORPORATION (US) | 2016-04-21 | — | — | US | disclosed |
| US-20160107973-A1 | SYNTHESIS OF INTERMEDIATES FOR PRODUCING PROSTACYCLIN DERIVATIVES | UNITED THERAPEUTICS CORPORATION (US) | 2016-04-21 | — | — | US | disclosed |
| US-20090131688-A1 | METHOD FOR THE SYNTHESIS OF 4-BENZOFURAN-CARBOXYLIC ACID | ZACH SYSTEM (FR) | 2009-05-21 | — | — | US | disclosed |
| US-6939866-B2 | Quinazoline derivatives | ASTRAZENECA AB (SE) | 2005-09-06 | — | — | US | disclosed |
| US-20040044015-A1 | Quinazoline derivatives | ASTRAZENECA AB (SE) | 2004-03-04 | — | — | US | disclosed |
| EP-1326860-A1 | QUINAZOLINE DERIVATIVES | AstraZeneca AB (SE) | 2003-07-16 | — | — | EP | disclosed |
| WO-2003047585-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING BENZOFURANYL SUBSTITUTED 3-CYANOQUINOLINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF SOLID TUMOURS | ASTRAZENECA AB (SE) | 2003-06-12 | — | — | WO | disclosed |
| WO-2003047584-A1 | QUINOLINE DERIVATIVES | ASTRAZENECA AB (SE) | 2003-06-12 | — | — | WO | disclosed |
| WO-2002030926-A1 | QUINAZOLINE DERIVATIVES | ASTRAZENECA AB (SE) | 2002-04-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10774027-B2 | Synthesis of intermediates for producing prostacyclin derivatives | PTGIS, PTGIR, PTGES | XDH 1155/4885CA12 3947/4885CA1 3256/4885 |
| US-20170158602-A1 | SYNTHESIS OF INTERMEDIATES FOR PRODUCING PROSTACYCLIN DERIVATIVES | PTGIS, PTGIR, PTGES | XDH 1155/4885CA12 3947/4885CA1 3256/4885 |
| US-20040044015-A1 | Quinazoline derivatives | NQO2, NRAS, TOP1 | XDH 51/4885CA12 1659/4885CA1 1790/4885 |
| US-20090131688-A1 | METHOD FOR THE SYNTHESIS OF 4-BENZOFURAN-CARBOXYLIC ACID | COASY, HSD17B12, ALDH18A1 | XDH 471/4885CA12 398/4885CA1 684/4885 |
| US-11225452-B2 | Synthesis of intermediates for producing prostacyclin derivatives | PTGIS, PTGIR, PTGS2 | XDH 1798/4885CA12 1597/4885CA1 1639/4885 |
| US-20220213020-A1 | SYNTHESIS OF INTERMEDIATES FOR PRODUCING PROSTACYCLIN DERIVATIVES | PTGIS, PTGIR, PTGES | XDH 1155/4885CA12 3947/4885CA1 3256/4885 |
| US-20190233362-A1 | SYNTHESIS OF INTERMEDIATES FOR PRODUCING PROSTACYCLIN DERIVATIVES | PTGIS, PTGIR, PTGES | XDH 1155/4885CA12 3947/4885CA1 3256/4885 |
| US-20160107973-A1 | SYNTHESIS OF INTERMEDIATES FOR PRODUCING PROSTACYCLIN DERIVATIVES | PTGIS, PTGIR, PTGES | XDH 1155/4885CA12 3947/4885CA1 3256/4885 |
| US-10196342-B2 | Synthesis of intermediates for producing prostacyclin derivatives | PTGIS, PTGIR, PTGES | XDH 1155/4885CA12 3947/4885CA1 3256/4885 |
| US-20200369592-A1 | SYNTHESIS OF INTERMEDIATES FOR PRODUCING PROSTACYCLIN DERIVATIVES | PTGIS, PTGIR, PTGES | XDH 1155/4885CA12 3947/4885CA1 3256/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.